GlaxoSmithKline Pharmaceuticals informs about board meeting

04 May 2016 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on May 25, 2016, to consider, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended March 31, 2016 and to recommend dividend, if any, on the equity shares of the Company.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

1995.45 -2.15 (-0.11%)
14-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.25
Dr. Reddys Lab 5861.00
Cipla 1356.95
Zydus Lifesciences 984.75
Lupin 1635.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.